These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16439445)
1. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Kawakami T; Chano T; Minami K; Okabe H; Okada Y; Okamoto K Hum Mol Genet; 2006 Mar; 15(6):821-30. PubMed ID: 16439445 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Liu MY; Poellinger L; Walker CL Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773 [TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277 [TBL] [Abstract][Full Text] [Related]
6. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development. Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Huang J; Zhang X; Zhang M; Zhu JD; Zhang YL; Lin Y; Wang KS; Qi XF; Zhang Q; Liu GZ; Yu J; Cui Y; Yang PY; Wang ZQ; Han ZG Carcinogenesis; 2007 May; 28(5):1094-103. PubMed ID: 17114643 [TBL] [Abstract][Full Text] [Related]
8. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908 [TBL] [Abstract][Full Text] [Related]
9. Methylation-associated silencing of TU3A in human cancers. Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805 [TBL] [Abstract][Full Text] [Related]
10. Methylation-associated silencing of SFRP1 in renal cell carcinoma. Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430 [TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma. Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761 [TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting at the Dlk1-Gtl2 locus caused by insertional mutagenesis in the Gtl2 5' region. Steshina EY; Carr MS; Glick EA; Yevtodiyenko A; Appelbe OK; Schmidt JV BMC Genet; 2006 Oct; 7():44. PubMed ID: 17014736 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of BHD in sporadic renal tumors. Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of maternal uniparental disomy 14 in patients with an epimutation and a deletion of the imprinted DLK1/GTL2 gene cluster. Buiting K; Kanber D; Martín-Subero JI; Lieb W; Terhal P; Albrecht B; Purmann S; Gross S; Lich C; Siebert R; Horsthemke B; Gillessen-Kaesbach G Hum Mutat; 2008 Sep; 29(9):1141-6. PubMed ID: 18454453 [TBL] [Abstract][Full Text] [Related]
16. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Sturm I; Stephan C; Gillissen B; Siebert R; Janz M; Radetzki S; Jung K; Loening S; Dörken B; Daniel PT Cell Death Differ; 2006 Apr; 13(4):619-27. PubMed ID: 16322756 [TBL] [Abstract][Full Text] [Related]
17. Molecular structure of bovine Gtl2 gene and DNA methylation status of Dlk1-Gtl2 imprinted domain in cloned bovines. Su H; Li D; Hou X; Tan B; Hu J; Zhang C; Dai Y; Li N; Li S Anim Reprod Sci; 2011 Aug; 127(1-2):23-30. PubMed ID: 21820255 [TBL] [Abstract][Full Text] [Related]
18. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation imprints on the IG-DMR of the Dlk1-Gtl2 domain in mouse male germline. Hiura H; Komiyama J; Shirai M; Obata Y; Ogawa H; Kono T FEBS Lett; 2007 Apr; 581(7):1255-60. PubMed ID: 17349634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]